PL2077729T3 - Doustne postacie dawkowania probiotyku - Google Patents
Doustne postacie dawkowania probiotykuInfo
- Publication number
- PL2077729T3 PL2077729T3 PL07839029T PL07839029T PL2077729T3 PL 2077729 T3 PL2077729 T3 PL 2077729T3 PL 07839029 T PL07839029 T PL 07839029T PL 07839029 T PL07839029 T PL 07839029T PL 2077729 T3 PL2077729 T3 PL 2077729T3
- Authority
- PL
- Poland
- Prior art keywords
- dosage forms
- oral dosage
- probiotic oral
- probiotic
- forms
- Prior art date
Links
- 239000006186 oral dosage form Substances 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/528,893 US9084434B2 (en) | 2006-09-27 | 2006-09-27 | Probiotic oral dosage forms |
PCT/US2007/020983 WO2008039531A1 (en) | 2006-09-27 | 2007-09-27 | Probiotic oral dosage forms |
EP07839029.1A EP2077729B1 (en) | 2006-09-27 | 2007-09-27 | Probiotic oral dosage forms |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2077729T3 true PL2077729T3 (pl) | 2014-11-28 |
Family
ID=38984310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07839029T PL2077729T3 (pl) | 2006-09-27 | 2007-09-27 | Doustne postacie dawkowania probiotyku |
Country Status (12)
Country | Link |
---|---|
US (2) | US9084434B2 (pl) |
EP (1) | EP2077729B1 (pl) |
JP (1) | JP5224606B2 (pl) |
CN (1) | CN101541194B (pl) |
AU (1) | AU2007300461B2 (pl) |
CA (1) | CA2664583C (pl) |
DK (1) | DK2077729T3 (pl) |
ES (1) | ES2500166T3 (pl) |
NZ (1) | NZ576078A (pl) |
PL (1) | PL2077729T3 (pl) |
PT (1) | PT2077729E (pl) |
WO (1) | WO2008039531A1 (pl) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008138805A1 (en) * | 2007-05-10 | 2008-11-20 | L'oreal | Cosmetic composition comprising an inulin derivative in the form of an emulsion expanded in volume |
CN102123693A (zh) | 2008-06-13 | 2011-07-13 | 奥洁克公司 | 产过氧化氢细菌用于牙齿增白的用途 |
US20110027420A1 (en) * | 2009-07-31 | 2011-02-03 | Haile Mehansho | Moisture migration reduction layer for a food product |
JP5606835B2 (ja) * | 2009-09-01 | 2014-10-15 | 大東化学株式会社 | 食品添加用被覆製剤及びその製造方法 |
WO2012009503A1 (en) * | 2010-07-14 | 2012-01-19 | Vertex Pharmaceuticals Incorporated | Palatable pharmaceutical composition comprising vx-950 |
WO2012031186A1 (en) | 2010-09-03 | 2012-03-08 | Wisconsin Pharmacal Company, Llc. | Prebiotic suppositories |
CN102604854B (zh) * | 2010-12-08 | 2014-06-18 | 益擎生技有限公司 | 新颖乳酸菌株及其调节免疫反应的用途 |
PT2481299T (pt) * | 2011-01-31 | 2017-03-08 | Synformulas Gmbh | Estirpes de bifidobacterium bifidum para aplicação em doenças gastrointestinais |
CN103648511B (zh) * | 2011-06-08 | 2018-12-07 | 诺沃奇梅兹有限公司 | 喷雾干燥的乳杆菌属菌株/细胞及其对抗幽门螺杆菌的用途 |
EP2532354A1 (de) * | 2011-06-08 | 2012-12-12 | OrganoBalance GmbH | Sprühgetrocknete Lactobacillus Stämme / Zellen und deren Verwendung gegen Helicobacter Pylori |
CN102204679B (zh) * | 2011-06-16 | 2013-01-30 | 内蒙古普泽生物制品有限责任公司 | 一种四联菌片及其制备方法 |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US10092614B2 (en) | 2011-09-09 | 2018-10-09 | Fédération Des Producteurs Acéricoles Du Québec | Nutriprotective diet |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
RU2015119462A (ru) * | 2012-10-25 | 2016-12-20 | Компани Жервэ Данон | Штаммы streptococcus thermophilus для лечения инфекции helicobacter pylori |
CN103169140B (zh) * | 2012-12-27 | 2015-03-11 | 北京中天神舟航天食品技术研究院 | 指示益生菌活度的可食用微胶囊及其制备方法和应用 |
ITMI20130476A1 (it) | 2013-03-28 | 2014-09-29 | Novintethical Pharma Sagl | Composizioni per il trattamento di disturbi gastro-intestinali a base di complessi di tannini con proteine |
US9403181B2 (en) * | 2013-07-26 | 2016-08-02 | Paul O'Malley | Oral care product formulation |
US9554973B2 (en) | 2013-07-26 | 2017-01-31 | Paul O'Malley | Micro-encapsulation of ozonated oils |
CN103859164A (zh) * | 2014-02-27 | 2014-06-18 | 扬州绿保生物科技有限公司 | 一种饲料添加剂的生产方法 |
CN104886255B (zh) * | 2014-03-07 | 2018-11-27 | 内蒙古伊利实业集团股份有限公司 | 具有缓解咽喉部炎症功效的益生菌食品组合物及食品 |
CN103876145B (zh) * | 2014-04-01 | 2016-06-01 | 吉林大学 | 一种益生菌微生态片剂及其制备方法 |
CN103876151A (zh) * | 2014-04-09 | 2014-06-25 | 吉林大学 | 一种益生菌微生态胶囊剂及其制备方法 |
CA2952080A1 (en) * | 2014-06-12 | 2015-12-30 | The Additive Advantage Llc | Method of applying flavor to chewing gum and other edible substrates |
CN104082744A (zh) * | 2014-07-09 | 2014-10-08 | 任发政 | 一种益生菌分散片及其制备方法 |
WO2016183531A1 (en) | 2015-05-13 | 2016-11-17 | Synlogic, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
TWI788111B (zh) * | 2015-01-02 | 2022-12-21 | 美商梅拉洛伊卡公司 | 多元補充品組成物 |
JP2018507872A (ja) * | 2015-03-09 | 2018-03-22 | バイオイミュナイザー・ソチエタ・ア・ガランツィア・リミタータBioimmunizer SAGL | ビフィズス菌およびプロバイオティクスから単離された細胞壁をともなう抗酸化剤の組み合わせを含むアンチエイジング組成物 |
EP3294757B1 (en) | 2015-05-13 | 2023-12-27 | Synlogic Operating Company, Inc. | Bacteria engineered to treat a disease or disorder |
WO2016210373A2 (en) | 2015-06-24 | 2016-12-29 | Synlogic, Inc. | Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof |
ITUB20152151A1 (it) * | 2015-07-14 | 2017-01-14 | Ergon Srl | Compressa ad elevata concentrazione di fermenti lattici |
WO2017040719A1 (en) | 2015-08-31 | 2017-03-09 | Synlogic, Inc. | Bacteria engineered to treat disorders in which oxalate is detrimental |
CN106822007B (zh) * | 2015-09-11 | 2021-12-31 | 西姆莱斯股份公司 | 口服制剂 |
AU2016346646B2 (en) | 2015-10-30 | 2022-12-01 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier |
WO2017075485A1 (en) | 2015-10-30 | 2017-05-04 | Synlogic, Inc. | Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental |
EP4095150A1 (en) | 2015-11-16 | 2022-11-30 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
WO2017123610A2 (en) | 2016-01-11 | 2017-07-20 | Synlogic, Inc. | Bacteria engineered to detoxify deleterious molecules |
WO2017123592A1 (en) | 2016-01-11 | 2017-07-20 | Synlogic, Inc. | Bacteria engineered to treat disorders associated with bile salts |
WO2017125845A1 (en) * | 2016-01-19 | 2017-07-27 | Synergia Life Sciences Pvt. Ltd | A liquid probiotic composition stable at ambient temperature |
US9855305B2 (en) * | 2016-03-29 | 2018-01-02 | Companion Therapeutics Llc | Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors |
EP3442545A4 (en) * | 2016-04-11 | 2020-01-08 | President and Fellows of Harvard College | PROBIOTIC FORMULATIONS FOR IMPROVING SPORTS PERFORMANCE |
SI3442547T1 (sl) | 2016-04-15 | 2023-11-30 | Baylor College Of Medicine | Lactobacillus reuteri MM4-1A za uporabo pri zdravljenju ali preprečevanju motenj avtističnega spektra |
WO2018026719A1 (en) * | 2016-08-01 | 2018-02-08 | Rhode Island Hospital | Probiotic bacteria-directed prevention or treatment of fungal infection |
CN106306284A (zh) * | 2016-08-30 | 2017-01-11 | 四川高福记生物科技有限公司 | 一种清除辣火锅痛点的乳酸菌压片糖果及其制备方法 |
KR20180046692A (ko) * | 2016-10-28 | 2018-05-09 | 롯데제과 주식회사 | 과민성 대장증후군 개선용 조성물 |
WO2018111023A1 (ko) * | 2016-12-16 | 2018-06-21 | (주)휴온스 | 안정성이 증진된 유산균 및 이의 제조방법 |
WO2018111024A1 (ko) * | 2016-12-16 | 2018-06-21 | (주)휴온스 | 안정성이 증진된 유산균 및 이의 제조방법 |
KR102004204B1 (ko) * | 2016-12-16 | 2019-07-26 | (주)휴온스 | 안정성이 증진된 유산균 및 이의 제조방법 |
EP3599899A1 (en) | 2017-03-23 | 2020-02-05 | Virun, Inc. | Stable dry powders and emulsions containing probiotics and mucoadhesive protein |
US10610541B2 (en) * | 2017-03-31 | 2020-04-07 | Vantage Specialties, Inc. | Prebiotics |
GB201708932D0 (en) * | 2017-06-05 | 2017-07-19 | Probi Ab | Microbial compositions |
AU2018290278B2 (en) | 2017-06-21 | 2022-12-15 | Synlogic Operating Company, Inc. | Bacteria for the treatment of disorders |
CN107307083A (zh) * | 2017-07-25 | 2017-11-03 | 石家庄以岭药业股份有限公司 | 一种燕麦味牛奶益生菌伴侣及其制备方法 |
AU2018307726C1 (en) | 2017-07-26 | 2023-03-30 | Tgx Soft Chew, Llc | Starch-free soft chew for veterinary applications |
CN107752031A (zh) * | 2017-10-26 | 2018-03-06 | 无限极(中国)有限公司 | 一种具有调节肠道菌群和保护胃粘膜功能的粉剂及其制备方法与应用 |
CN107752039A (zh) * | 2017-11-21 | 2018-03-06 | 常州市阿曼特化工有限公司 | 一种益生菌菌剂的制备方法 |
US11850270B2 (en) * | 2017-12-04 | 2023-12-26 | The BioCollective, LLC | Probiotics and methods of use |
CN108113003A (zh) * | 2017-12-15 | 2018-06-05 | 浙江康诺邦健康产品有限公司 | 一种适合婴幼儿的益生菌软胶囊及其制备方法 |
CN108004189B (zh) * | 2018-01-18 | 2021-07-27 | 北京科拓恒通生物技术股份有限公司 | 一种复合益生乳酸菌粉剂及其制备方法与应用 |
US11045507B2 (en) | 2019-02-21 | 2021-06-29 | Ewelina Sosnowska-Turek | Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30 |
US20220257732A1 (en) | 2019-04-29 | 2022-08-18 | Synlogic Operating Company, Inc. | Enumeration of genetically engineered microorganisms by live cell counting techniques |
CN110384240A (zh) * | 2019-08-01 | 2019-10-29 | 上海宣泰生物科技有限公司 | 降血糖的维生素和益生菌发酵物粉营养组合物及其应用 |
IT201900016811A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali |
TW202126317A (zh) | 2019-09-24 | 2021-07-16 | 美商普拉塔生技公司 | 用於治療發炎和免疫疾病之組成物和方法 |
CN111280449B (zh) * | 2020-02-11 | 2022-11-11 | 浙江华康药业股份有限公司 | 一种肠内缓释糖醇添加剂及其制备方法和应用 |
CN115298308A (zh) | 2020-03-20 | 2022-11-04 | 同生运营公司 | 经工程化以减轻高苯丙氨酸血症的微生物 |
CN111567809A (zh) * | 2020-05-26 | 2020-08-25 | 奥克斯路株式会社 | 具有提高免疫力和调节肠道功能的动物双歧杆菌bz11复合菌剂 |
CN111671090A (zh) * | 2020-05-26 | 2020-09-18 | 颜如玉医药科技有限公司 | 一种益生菌组合物及其制剂 |
AU2021393455A1 (en) | 2020-12-02 | 2023-06-29 | Synlogic Operating Company, Inc. | Engineered microorganisms |
CN116847860A (zh) | 2020-12-31 | 2023-10-03 | 同生运营公司 | 经工程化以减轻高苯丙氨酸血症的微生物 |
EP4277634A1 (en) | 2021-01-12 | 2023-11-22 | Prolacta Bioscience, Inc. | Synbiotic treatment regimens |
WO2022221273A1 (en) | 2021-04-13 | 2022-10-20 | Synlogic Operating Company, Inc. | Bacteria engineered to secrete active proteins |
BE1029673B1 (nl) * | 2021-08-13 | 2023-03-13 | Zinkh Nv | Probiotische samenstelling voor verbeterde orale gezondheid |
WO2023044479A1 (en) | 2021-09-17 | 2023-03-23 | Synlogic Operating Company, Inc. | Methods for reducing hyperphenylalaninemia |
CN114601019A (zh) * | 2022-03-30 | 2022-06-10 | 广州瑞铂茵健康科技有限公司 | 胎盘水溶性提取物作为壁材制备益生菌微胶囊的应用 |
WO2023245168A1 (en) | 2022-06-17 | 2023-12-21 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof |
WO2023245171A1 (en) | 2022-06-17 | 2023-12-21 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof |
WO2023250478A1 (en) | 2022-06-23 | 2023-12-28 | Synlogic Operating Company, Inc. | Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof |
WO2024081768A1 (en) | 2022-10-12 | 2024-04-18 | Synlogic Operating Company, Inc. | Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses |
WO2024086557A1 (en) | 2022-10-17 | 2024-04-25 | Synlogic Operating Company, Inc. | Recombinant bacteria expressing phenylalanine ammonia lyase, phenylalanine transporter and l- aminoacid deaminase for reducing hyperphenylalaninemia |
WO2024129974A1 (en) | 2022-12-14 | 2024-06-20 | Synlogic Operating Company, Inc. | Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental |
WO2024130119A2 (en) | 2022-12-16 | 2024-06-20 | Prolacta Bioscience, Inc. | Synbiotic compositions for short chain fatty acid production |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1427100A (fr) | 1964-12-14 | 1966-02-04 | Ile De Rech Pharma Et Therapeu | Procédé pour l'obtention d'hydroxyflavanne-3-4-diols |
US4518696A (en) | 1983-01-11 | 1985-05-21 | Chr. Hansen's Laboratory, Inc. | Stabilized liquid bacterial suspension for oral administration to animals |
JPS6023321A (ja) | 1983-07-19 | 1985-02-05 | Hohnen Oil Co Ltd | 長期保存に耐えるビフイズス菌製剤の製造法 |
US4698360B1 (en) | 1985-04-09 | 1997-11-04 | D Investigations Pharmacologiq | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
JPS62207286A (ja) * | 1986-03-07 | 1987-09-11 | Meiji Seika Kaisha Ltd | ビフイズス菌増殖促進物およびその製造法 |
JPS63227507A (ja) | 1987-03-17 | 1988-09-21 | Ibaraki Pref Gov | フザリウム生菌製剤 |
JPH05255097A (ja) | 1992-01-24 | 1993-10-05 | Miyarisan Seibutsu Igaku Kenkyusho:Kk | 液状組成物 |
US5733568A (en) | 1993-12-03 | 1998-03-31 | Lafor Laboratories Limited | Micro-encapsulated lactobacilli for medical applications |
UA39965C2 (uk) | 1993-12-03 | 2001-07-16 | Лайфор Леборетріз Лтд | Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти ) |
EP0955058B1 (en) | 1997-01-09 | 2004-05-26 | Morinaga Milk Industry Co., Ltd. | Lactoferrin tablets |
EP0931543B1 (de) | 1997-12-19 | 2002-03-20 | MERCK PATENT GmbH | Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien |
JP3942716B2 (ja) | 1998-01-20 | 2007-07-11 | 森永乳業株式会社 | アロエ錠剤 |
US6706287B2 (en) | 2001-05-15 | 2004-03-16 | Kibow Biotech Inc. | Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
JP2001089397A (ja) | 1999-09-17 | 2001-04-03 | Morinaga Milk Ind Co Ltd | 生理活性物質含有錠剤及びその製造方法 |
JP3478773B2 (ja) | 1999-12-21 | 2003-12-15 | 日東薬品工業株式会社 | 生菌組成物 |
EP1151673A3 (en) * | 2000-05-03 | 2002-01-02 | Societe Des Produits Nestle S.A. | Confectionery product having a filling |
FI20001402A (fi) | 2000-06-13 | 2001-12-14 | Yves Delatte | Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi |
AU2001272369A1 (en) | 2000-07-17 | 2002-01-30 | Chr. Hansen A/S | Methods and formultations with probiotic microorganisms and medicaments |
JP3399919B2 (ja) | 2000-09-26 | 2003-04-28 | 株式会社ヤクルト本社 | 発酵乳食品 |
US7214370B2 (en) | 2000-12-18 | 2007-05-08 | Probiohealth, Llc | Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
US20040197277A1 (en) | 2001-08-24 | 2004-10-07 | The Procter & Gamble Company | Chewable compositions with probiotic agents |
US7208186B2 (en) | 2001-09-18 | 2007-04-24 | Spi Pharma, Inc. | Chewing gum formulation and method of making the same |
US7118765B2 (en) | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
CA2479735C (en) * | 2002-03-20 | 2011-05-17 | Elan Pharma International Ltd. | Fast dissolving dosage forms having reduced friability |
JP3818319B2 (ja) | 2003-08-21 | 2006-09-06 | 大塚製薬株式会社 | 粘膜免疫賦活作用を有する乳酸菌 |
EP1675617B1 (en) | 2003-09-30 | 2017-07-26 | Kibow Biotech, Inc. | Compositions for augmenting kidney function |
WO2005060937A1 (en) | 2003-12-23 | 2005-07-07 | Chr. Hansen A/S | Compressed tablets comprising viable probiotic microorganisms |
GB0330009D0 (en) | 2003-12-24 | 2004-01-28 | Ferrosan As | Probiotic tablet formulations |
DE102004026706A1 (de) | 2004-05-28 | 2005-12-15 | Merck Patent Gmbh | Orale Darreichungsform enthaltend probiotische Bakterien |
US20060093592A1 (en) | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
SE529185C2 (sv) | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
CN102479952B (zh) | 2010-11-23 | 2014-10-08 | 清华大学 | 锂离子电池电极复合材料及其制备方法以及电池 |
-
2006
- 2006-09-27 US US11/528,893 patent/US9084434B2/en not_active Expired - Fee Related
-
2007
- 2007-09-27 DK DK07839029.1T patent/DK2077729T3/da active
- 2007-09-27 ES ES07839029.1T patent/ES2500166T3/es active Active
- 2007-09-27 PT PT78390291T patent/PT2077729E/pt unknown
- 2007-09-27 PL PL07839029T patent/PL2077729T3/pl unknown
- 2007-09-27 CA CA2664583A patent/CA2664583C/en not_active Expired - Fee Related
- 2007-09-27 WO PCT/US2007/020983 patent/WO2008039531A1/en active Application Filing
- 2007-09-27 CN CN2007800441746A patent/CN101541194B/zh not_active Expired - Fee Related
- 2007-09-27 NZ NZ576078A patent/NZ576078A/en not_active IP Right Cessation
- 2007-09-27 EP EP07839029.1A patent/EP2077729B1/en not_active Not-in-force
- 2007-09-27 JP JP2009530438A patent/JP5224606B2/ja not_active Expired - Fee Related
- 2007-09-27 AU AU2007300461A patent/AU2007300461B2/en not_active Ceased
-
2015
- 2015-07-20 US US14/803,647 patent/US9549984B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20090117056A1 (en) | 2009-05-07 |
EP2077729B1 (en) | 2014-04-23 |
ES2500166T3 (es) | 2014-09-30 |
AU2007300461B2 (en) | 2013-09-26 |
NZ576078A (en) | 2011-06-30 |
AU2007300461A2 (en) | 2009-06-11 |
PT2077729E (pt) | 2014-07-28 |
CN101541194B (zh) | 2013-09-25 |
CA2664583A1 (en) | 2008-04-03 |
US9549984B2 (en) | 2017-01-24 |
AU2007300461A1 (en) | 2008-04-03 |
US9084434B2 (en) | 2015-07-21 |
US20150359894A1 (en) | 2015-12-17 |
WO2008039531A1 (en) | 2008-04-03 |
JP2010504981A (ja) | 2010-02-18 |
CA2664583C (en) | 2014-12-02 |
JP5224606B2 (ja) | 2013-07-03 |
CN101541194A (zh) | 2009-09-23 |
DK2077729T3 (da) | 2014-07-28 |
EP2077729A1 (en) | 2009-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2077729E (pt) | Formas orais probióticas | |
IL206159A0 (en) | Oral pharmaceutical dosage forms | |
PL2399579T3 (pl) | Farmaceutyczne postacie dawkowania | |
PL1935395T3 (pl) | Doustna kompozycja | |
IL199191A0 (en) | Modified release ibuprofen solid oral dosage form | |
IL205160A0 (en) | Oral dosage forms comprising licarbazepine acetate | |
EP2011482A4 (en) | SOLID PREPARATION FOR ORAL APPLICATION | |
PL2167033T4 (pl) | Podawana raz dziennie doustna postać dawkowania zawierająca takrolimus | |
HK1154484A1 (en) | Oral dosage composition | |
GB0710439D0 (en) | Oral dosage form | |
HK1129566A1 (en) | Oral preparation comprising pioglitazone | |
IL194366A0 (en) | Solid dosage formulations | |
IL184787A0 (en) | Oral dosage form comprising rosiglitazone | |
IL184790A0 (en) | Oral dosage form comprising rosiglitazone | |
HK1206267A1 (en) | Stabilized picoplatin oral dosage form | |
GB0616794D0 (en) | Solid dosage form | |
IL198760A0 (en) | Oral formulations | |
GB0822124D0 (en) | Oral dosage form | |
EP2156842A4 (en) | ORAL COMPOSITION | |
ZA200810854B (en) | Oral hygiene | |
HK1115054A1 (en) | Preparation for oral administration | |
GB0616860D0 (en) | Mouth Snagger | |
GB0704123D0 (en) | Dosage form |